drugset / Trial / NCT00628394
Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
Phase 4
Completed
119 enrolled
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH) · collabStanley Medical Research Institute · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This research is being done because people with schizophrenia often have problems with thinking including learning, remembering, paying attention, and problem solving. During this study, we will test if cognitive remediation (computer games made to improve thinking), used along with a drug called atomoxetine, may help the problems in thinking as well as some of the symptoms of schizophrenia.
Timeline
- Start
- 2003-09
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | 40 mg | Oral |